SIOUX FALLS, S.D., Aug. 09, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully human…
The key benchmark indices are likely to start trade on a weak note mirroring the bearish sentiment across global markets, after the Russian President ordered troops to launch…
Sputnik V has demonstrated efficacy of 97.6% and has already received Emergency Usage Authorisation in India.The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Panacea Biotec on Tuesday announced the shipment of…